ONCoV-Logo_WhiteFont.png

Ontario’s COVID-19 Genomics Rapid Response Coalition 

 

    About    

To accelerate the genomic characterization and surveillance of SARS-CoV-2 in Ontario and to help expedite patient genome sequencing through a coordinated approach bringing together all of the province’s genomics resources and capacity to enable timely and comprehensive genomic analysis.

Genomics

Infrastructure

Standardized Sequencing Methodologies

Bioinformatics

Infrastructure

Data Management & Sharing

The ON-CoV Coalition is designed to provide for method standardization and coordination of:

1

Collecting Patient Samples and Metadata

2

Sequencing

3

Data Curation and Management

4

Epidemiological Studies 

This work will expedite real-time testing and reporting to inform public health and public policy, help manage and overcome the ongoing COVID-19 crisis and ensure scalability for Ontario’s future pandemics preparedness.

Why Genomics?

Genomic technologies are the foundation for the solutions necessary to combat the ongoing COVID-19

pandemic. Ontario’s world-leading expertise in genomics, bioinformatics, genomics epidemiology, and artificial intelligence, can expedite Ontario’s response to COVID-19. 

The results reported by the Coalition will inform vaccine and therapeutic development.

Why Ontario Genomics?

Over the past 20 years, Ontario Genomics, together with the Ontario Government, Genome Canada, and academic, clinical and industry partners, has built a world-leading genomics ecosystem in Ontario with over $2.7B in funding leveraged for research, translation and the establishment of genomic technology platforms. 

Ontario Genomics is well-positioned to provide and promote:
W-Collaboration.png
COLLABORATION
W-Leadership.png
LEADERSHIP
W-Expertise.png
EXPERTISE
 

    Members    

ONCoV Genomics Coalition Members

W-ACampigotto.jpg

Aaron Campigotto

University of Toronto

W-BHamelin.jpg

Bettina Hamelin

Ontario Genomics

W-SMubareka.jpg

Samira Mubareka

Sunnybrook Health Sciences / University of Toronto

W-DBrabant-Kirwan.jpg

Danielle Brabant-Kirwan

Health Sciences North

W-RLee.jpg

Robyn Lee

Dalla Lana School of Public Health, University of Toronto

W-LNPenno.jpg

Letitia Nadalin Penno

Canadore College

W-NFittipaldi.jpg

Nahuel Fittipaldi

Public Health Ontario

W-AMcArthur.jpg

Andrew G. McArthur

McMaster University

W-MFiume.jpg

Marc Fiume

DNAstack

W-AMcGregor.jpg

Allison McGeer

Sinai Health Systems

W-SScherer.jpg

Stephen Scherer

Hospital for Sick Children / University of Toronto

TCAG / CGEn

W-PSheth.jpg

Prameet M. Sheth

Kingston Health Sciences Centre / Queen’s University

W-JSimpson.jpg

Jared Simpson

Ontario Institute for Cancer Research

W-MSzego.jpg

Michael Szego

Unity Health Toronto / University of Toronto

W-DVilleneuve.jpg

David Villeneuve

Canadore College

W-BWang.jpg

Bo Wang

Peter Munk Cardiac Centre, UHN / University of Toronto

W-SWootton.jpg

Sarah Wootton

University of Guelph

 

We are proactively working with the research community, partner genome centres, and governments to accelerate the genomic characterization and surveillance of SARS-CoV-2 in Ontario. Learn more and stay up-to-date about our COVID-19 programs and important resources.

 

    Partners    

LOGO_OG.png
LOGO_GenomeCanada.png
LOGO_CanCOGeN.png
LOGO_Public Health Agency of Canada.png
LOGO_Public Health Ontario.png
LOGO_TCAG.png
LOGO_OICR Color.png
LOGO_EORLA.png
LOGO_CDIC.png
LOGO_CGen_edited_edited_edited_edited.pn
LOGO_DNAstack.png
LOGO_Oxford Nanopore Technologies.png
LOGO_Illumina.png
LOGO_Vector Institute.png
LOGO_McMaster.png
LOGO_University of Toronto.png
LOGO_Canadore College.png
LOGO_Dalla Lana.png
LOGO_Sunnybrook.png
LOGO_UHN-PeterMunk.png
LOGO_Michael Garron Hospital (TEGH).png
LOGO_London Health Sciences Centre.gif
LOGO_SickKids.png
LOGO_Sinai Health System.png
LOGO_Unity Health Toronto.png
LOGO_Health Sciences North.png
LOGO_North York General Hospital.png
LOGO_The Scarborough Hospital.png
LOGO_Hamilton Health Sciences Centre.png
LOGO_Kingston%20General%20Hospital_edite
LOGO_St. Joseph's Healthcare Hamilton.pn
 

2 years into the pandemic, burning questions remain about COVID-19 — and how we fight it 

March 11, 2022

Two years into the pandemic, questions remain about COVID-19 and how we fight it. Scientists like Dr. Samira Mubareka, part of the first Canadian research team to isolate SARS-CoV-2 and study its genetics are striving to unpack what makes this unique pathogen tick. We’re honoured to have Dr. Mubareka as an impactful member of our ONCoV initiative. 

Plan for testing after N.B. lifts COVID-19 restrictions remains unclear 

March 1, 2022

As restrictions end, there is "absolutely" the risk another wave could be on the way with the new BA2 subvariant of the Omicron variant spreading in Canada, said Dr. Allison McGeer, infectious disease physician at Sinai Health System in Toronto and a member of our ONCoV initiative. 

The good and bad news on Omicron subvariant BA.2 as it continues to spread in Ontario

February 24, 2022

The good and bad news on the Omicron subvariant BA.2 as it continues to spread in Ontario - “Even though we’re all concerned about this Omicron subvariant, I think there are reasons to be optimistic,” said Catalina Lopez-Correa, CSO at Genome Canada leading CanCOGeN, which Ontario Genomics actively supports.

    Contact    

 

Thanks for submitting!